Dr Lindsay Rosenwald, Biography.
Wall Street Transcript Interview (2018)
IDB Bank Profile
Biography (2011) LR Facts*, below.
For...
Orchestra BioMed™ Announces Completion of $41 Million Financing.
November 15, 2018
Capital proceeds to support late-stage clinical development of lead cardiovascular product candidates for artery disease and...
Immunomedics Chairman Buys $19 Million More in Stock.
(Barrons) Two weeks ago, B. Riley analyst Madhu Kumar gushed about Immunomedics, writing in a report that the biotech could have a “blockbuster cancer drug” in IMMU-132,...
Steven Boyd, Armistice Capital Ranked #2 in Rising Hedge Fund Stars (Institutional Investor Magazine).
A handful were born outside the U.S., while others are first-generation Americans. Some were shoo-ins for the Ivy League, while several relied...
Internet Stock Review Initiates Coverage On HealthLynked Corp. (HLYK) $0.23.
NAPLES, Fla., Oct. 04, 2017 (GLOBE NEWSWIRE) -- HealthLynked Corp. (HLYK) today announced it has retained Institutional Analyst Inc., to provide coverage...
Bradley Rotter: Cybersecurity: AI, Friend or Foe?
Applied AI Conference 2017
https://youtu.be/VcNXvqdsKMI?si=Ze_a_LHMrkb-4ksk
The Applied AI Conference is...
Added to Watch List $1.32, Dyadic Inc (DYAI) Announces $5 Million Stock Buyback.
CLICK TO VIEW REPORT
Adding Dicerna (DRNA) $3.30 to Watch List.
Adding Dicerna (DRNA) $3.30 to Watch List.
How fun would it be to sell a $3.00 idea (IMMU) at...
Adding Immunomedics (IMMU) $3.00 to Watch List.
Biotech Stock Review Initiates Coverage.
Immunomedics (IMMU). $3.00 Epic Short Squeeze Inflection Point Nears.
CNS Wellness, Leading Brain Research and Treatment Technology Company Hits Ground Running.
“Announces Partnership With Caron Foundation, Ranked Amongst Top 7 Treatment Centers in US with Revenues Approaching $100 million.”
Latest article
GeoVax (GOVX) Provides First Half 2024 Business Update.
Award of BARDA Project NextGen contract represents a significant milestone event;
Total value...
Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.
Can You Imagine Selling Solgenix at $2.00 yesterday.
And to be honest, news wasn't all that big - such...
Nine Page Summary Report on GeoVax (GOVX)
This is a great long-term story. We’re telling you.
When we finished writing our earlier 44-page report,...
